Smilax Laboratories

Hyderabad, Telangana, India
Hybrid — also manufactures internal programs
Small Molecule API Intermediates Oral Solid Dose
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Smilax Laboratories

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Hyderabad, Telangana, India
Website
Modalities
Small Molecule API, Intermediates, Oral Solid Dose
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Smilax Laboratories

Smilax Laboratories makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Oral Solid Dose. 2 manufacturing sites registered with the U.S. FDA. Website: https://smilaxlabs.com/cdmo-and-cmo/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Smilax Laboratories FDA Inspection History

2023-09
NAI VAI OAI
Date Site Type Observations Classification
2023-09-15
Smilax Laboratories Limited
Parawada- Vishakapatnam District Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Smilax Laboratories

How many FDA inspections does Smilax Laboratories have on record?
CDMO Signal tracks 1 FDA inspection for Smilax Laboratories, sourced from the FDA inspection database. See the full inspection history above.
Has Smilax Laboratories received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Smilax Laboratories.
Does Smilax Laboratories have a CDMO Signal Score?
Not yet. Smilax Laboratories is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Smilax Laboratories for a manufacturing program?
Use the free AI matchmaker to compare Smilax Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Shanghai Desano
Shanghai, China
Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
PharmaBlock
Nanjing, Jiangsu, China
Small Molecule API, Intermediates, Oral Solid Dose
Viwit Pharmaceutical
Zaozhuang, Shandong, China
Small Molecule API, Intermediates, Oral Solid Dose, Sterile Injectables
Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose

Compare Smilax Laboratories with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Smilax Laboratories
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.